Zentynel is a Vitacura, Chile-based venture capital firm investing in early-stage biotechnology and life sciences companies across Latin America, with observed U.S. activity. Its One Health strategy spans human and animal health, HealthTech, AgTech, FoodTech, environmental biotechnology, pharmaceuticals, medical devices and oncology. The firm typically invests US$1 million to US$2 million per company and reserves follow-on capital.